Literature DB >> 27071999

Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging.

Aaron F Jolly1,2, Gregory S Thomas3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27071999     DOI： 10.1007/s12350-016-0484-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

1.  Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.

Authors:  Z Gao; Z Li; S P Baker; R D Lasley; S Meyer; E Elzein; V Palle; J A Zablocki; B Blackburn; L Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  2001-07       Impact factor: 4.030

2.  Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.

Authors:  Hsiao D Lieu; John C Shryock; Gregory O von Mering; Toufigh Gordi; Brent Blackburn; Ann W Olmsted; Luiz Belardinelli; Richard A Kerensky
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function.

Authors:  Toufigh Gordi; Brent Blackburn; Hsiao Lieu
Journal:  J Clin Pharmacol       Date:  2007-07       Impact factor: 3.126

4.  Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial".

Authors:  Rami Doukky; Raysa Morales Demori; Sidharth Jain; Roy Kiriakos; Victor Mwansa; James E Calvin
Journal:  J Nucl Cardiol       Date:  2012-03-07       Impact factor: 5.952

Review 5.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

6.  The absolute bioavailability of caffeine in man.

Authors:  J Blanchard; S J Sawers
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Antinociceptive effects of novel A2B adenosine receptor antagonists.

Authors:  Osama M Abo-Salem; Alaa M Hayallah; Andras Bilkei-Gorzo; Barbara Filipek; Andreas Zimmer; Christa E Müller
Journal:  J Pharmacol Exp Ther       Date:  2003-10-16       Impact factor: 4.030

8.  Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

Authors:  Jesse A Doran; Waseem Sajjad; Marabel D Schneider; Rohit Gupta; Maria L Mackin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-03-29       Impact factor: 5.952

9.  The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

Authors:  Gregory S Thomas; Randall C Thompson; Michael I Miyamoto; Tze K Ip; Deborah L Rice; Douglas Milikien; Hsiao D Lieu; Vandana S Mathur
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

10.  Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study.

Authors:  Furqan H Tejani; Randall C Thompson; Rita Kristy; Stan Bukofzer
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-17       Impact factor: 2.357
View more
  3 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

Review 2.  Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR.

Authors:  Aiden Abidov; Vasken Dilsizian; Rami Doukky; W Lane Duvall; Christopher Dyke; Michael D Elliott; Fadi G Hage; Milena J Henzlova; Nils P Johnson; Ronald G Schwartz; Gregory S Thomas; Andrew J Einstein
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-20       Impact factor: 5.364

3.  Buccal caffeine strips for reversal of adverse symptoms of vasodilator stress.

Authors:  Mohammed Elsadany; Bryan Stringer; Josiah Bote; Khaled H Abdulla; Jesse A Doran; Ronald G Schwartz; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2022-07-06       Impact factor: 3.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.